SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-088231
Filing Date
2021-07-01
Accepted
2021-07-01 16:08:38
Documents
3
Period of Report
2021-06-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2121272d1_8k.htm 8-K 27598
2 EXHIBIT 99.1 tm2121272d1_ex99-1.htm EX-99.1 11255
3 GRAPHIC image_001.gif GRAPHIC 3150
  Complete submission text file 0001104659-21-088231.txt   44524
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Filer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39788 | Film No.: 211065929
SIC: 2834 Pharmaceutical Preparations